Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 86
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04595565 | Sacituzumab Govitecan in Primary HER2-negative Breast Cancer | ||
| NCT02160353 | Neo-adjuvant Abiraterone Prostate Study | ||
| NCT03862911 | Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer | ||
| NCT01158287 | Sorafenib. ICORG 06-41, V4 | ||
| NCT00973947 | Customized Headrest or Standard Headrest in Holding Patients Still While Undergoing Radiation Therapy for Head and Neck Cancer | ||
| NCT01164150 | Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06 | ||
| NCT02050737 | Plasma Biomarkers C-RAC, ICORG 12-27, V1 | ||
| NCT04617067 | Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic Cancer | ||
| NCT06149546 | Exploring the Impact of a Multi-modal Nutritional Intervention in Patients Undergoing Chemotherapy for Pancreatic Cancer (FEED Trial) | ||
| NCT00470236 | Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast | ||
| NCT00809211 | Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia | ||
| NCT04667663 | CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma. | ||
| NCT01101425 | Male Breast Cancer: Understanding the Biology for Improved Patient Care | ||
| NCT00814541 | PAD. ICORG 05-01, V11 | ||
| NCT00951535 | A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17 | ||
| NCT01726452 | NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS) | ||
| NCT00911716 | TC Avastin. ICORG 08-10, V6 | ||
| NCT01160731 | Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | ||
| NCT00513877 | Bortezomib in Treating Patients With Malignant Pleural Mesothelioma | ||
| NCT02225704 | Radium-223 in Combination With Enzalutamide | ||
| NCT01450449 | Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme | ||
| NCT06078813 | Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases | ||
| NCT03843346 | The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer | ||
| NCT04581070 | The COVID-IYON Study - Study Examining Data Pertaining to Clinical Outcomes and Organisational Responses to the 2020 SARS-CoV-2 Pandemic" | ||
| NCT02446405 | Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer | ||
| NCT03869762 | Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases. | ||
| NCT00962312 | Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer | ||
| NCT04136353 | Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate | ||
| NCT02177110 | A Translational Systems Medicine Approach to Provide Predictive Capacity for Therapy Response in Advanced or Metastatic Malignant Melanoma | ||
| NCT06024824 | Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas) | ||
| NCT01722851 | Circulating miRNAs. | ||
| NCT01822444 | ANGIOPREDICT. ICORG 12-16, V3 | ||
| NCT03699111 | Identification of New Patient Stratification Tools in MSS RAS mt mCRC | ||
| NCT01840306 | Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer | ||
| NCT00949338 | Comparing Two Sets of Bladder-Filling Instructions in Treating Patients Undergoing Radiation Therapy For Prostate Cancer. ICORG 05-04 | ||
| NCT02194842 | Phase III Radium 223 mCRPC-PEACE III | ||
| NCT00755976 | Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma | ||
| NCT02705859 | Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study) | ||
| NCT05518110 | PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer | ||
| NCT01722890 | CharactHer. ICORG 12-09, V3 | ||
| NCT02050997 | Plasma Biomarkers P-DAC, V1 | ||
| NCT05974774 | Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors | ||
| NCT00968643 | Spinal Cord Compression. ICORG 05-03, V6 | ||
| NCT00958321 | Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35 | ||
| NCT03162003 | Irish Programme for Stratified Prostate Cancer Therapy | ||
| NCT01726309 | Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4 | ||
| NCT04116047 | CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC) | ||
| NCT00974610 | Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer. | ||
| NCT01721252 | Tarceva. ICORG 08-41 | ||
| NCT01495884 | The Myocet/Lapatinib Study. ICORG 10-03, V5 |
